Dr. Aseem Malhotra

as an independent risk factor did not become apparent as a risk factor for heart disease unless it was at least above 250 or 300. And most, 99% of people, Megan, don't have LDL cholesterol that high. And then we did further research in this group of people that have got a very high LDL genetically called familial hyperlipidemia that affects one in 250 people. Let's just look at those.

as an independent risk factor did not become apparent as a risk factor for heart disease unless it was at least above 250 or 300. And most, 99% of people, Megan, don't have LDL cholesterol that high. And then we did further research in this group of people that have got a very high LDL genetically called familial hyperlipidemia that affects one in 250 people. Let's just look at those.

as an independent risk factor did not become apparent as a risk factor for heart disease unless it was at least above 250 or 300. And most, 99% of people, Megan, don't have LDL cholesterol that high. And then we did further research in this group of people that have got a very high LDL genetically called familial hyperlipidemia that affects one in 250 people. Let's just look at those.

And this is published in BMJ evidence-based medicine period. People can look this up, mean number of scientists. And we found that in people with very, very high levels of LDL cholesterol above 300, for example, there was no difference in the ones that develop heart disease and their LDL levels and the ones that did develop heart disease.

And this is published in BMJ evidence-based medicine period. People can look this up, mean number of scientists. And we found that in people with very, very high levels of LDL cholesterol above 300, for example, there was no difference in the ones that develop heart disease and their LDL levels and the ones that did develop heart disease.

And this is published in BMJ evidence-based medicine period. People can look this up, mean number of scientists. And we found that in people with very, very high levels of LDL cholesterol above 300, for example, there was no difference in the ones that develop heart disease and their LDL levels and the ones that did develop heart disease.

And therefore, that is another nail in the coffin to this LDL theory hypothesis that it causes heart disease. It's basically, I would say, a trillion dollar industry. It's a trillion dollar scam. The statin benefit that I mentioned, 1%, is there from the trials.

And therefore, that is another nail in the coffin to this LDL theory hypothesis that it causes heart disease. It's basically, I would say, a trillion dollar industry. It's a trillion dollar scam. The statin benefit that I mentioned, 1%, is there from the trials.

And therefore, that is another nail in the coffin to this LDL theory hypothesis that it causes heart disease. It's basically, I would say, a trillion dollar industry. It's a trillion dollar scam. The statin benefit that I mentioned, 1%, is there from the trials.

Having said that, another caveat, again, Megan, which is what we need to do and change the system with Maha, is that these drug trials have never been independently evaluated. So we have to trust drug companies. But let's just say it is true that it's 1% benefit. That's because statins have an independent effect where they are slightly anti-clotting and anti-inflammatory.

Having said that, another caveat, again, Megan, which is what we need to do and change the system with Maha, is that these drug trials have never been independently evaluated. So we have to trust drug companies. But let's just say it is true that it's 1% benefit. That's because statins have an independent effect where they are slightly anti-clotting and anti-inflammatory.

Having said that, another caveat, again, Megan, which is what we need to do and change the system with Maha, is that these drug trials have never been independently evaluated. So we have to trust drug companies. But let's just say it is true that it's 1% benefit. That's because statins have an independent effect where they are slightly anti-clotting and anti-inflammatory.

And heart disease is an inflammatory condition linked to abnormal clotting and insulin resistance. When you look at all the other drugs that lower cholesterol or diet, just lowering LDL cholesterol, again, I was involved in this research published in BMDA, evidence-based medicine. We looked at this and we found no relationship.

And heart disease is an inflammatory condition linked to abnormal clotting and insulin resistance. When you look at all the other drugs that lower cholesterol or diet, just lowering LDL cholesterol, again, I was involved in this research published in BMDA, evidence-based medicine. We looked at this and we found no relationship.

And heart disease is an inflammatory condition linked to abnormal clotting and insulin resistance. When you look at all the other drugs that lower cholesterol or diet, just lowering LDL cholesterol, again, I was involved in this research published in BMDA, evidence-based medicine. We looked at this and we found no relationship.

So lowering cholesterol per se does not prevent heart attacks or stroke. This is an absolute- What does? Okay. All right. So the main driver of heart disease, the number one sort of risk factor is insulin resistance, which basically is linked to five markers. And that's why I set up this program called Metabolic Health, which is very easy to measure, very simple.

So lowering cholesterol per se does not prevent heart attacks or stroke. This is an absolute- What does? Okay. All right. So the main driver of heart disease, the number one sort of risk factor is insulin resistance, which basically is linked to five markers. And that's why I set up this program called Metabolic Health, which is very easy to measure, very simple.

So lowering cholesterol per se does not prevent heart attacks or stroke. This is an absolute- What does? Okay. All right. So the main driver of heart disease, the number one sort of risk factor is insulin resistance, which basically is linked to five markers. And that's why I set up this program called Metabolic Health, which is very easy to measure, very simple.

Most doctors aren't having these conversations with patients, which is basically looking at two markers of your cholesterol profile, triglycerides and HDL, so-called good cholesterol, your waist circumference, Megan, whether you have a high blood pressure or what we call pre-high blood pressure, pre-hypertension, or whether you're pre-diabetic or type 2 diabetic.

Most doctors aren't having these conversations with patients, which is basically looking at two markers of your cholesterol profile, triglycerides and HDL, so-called good cholesterol, your waist circumference, Megan, whether you have a high blood pressure or what we call pre-high blood pressure, pre-hypertension, or whether you're pre-diabetic or type 2 diabetic.